Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.Alison M Schram,Nicoletta Colombo,Edward Arrowsmith,Vivek Narayan,Kan Yonemori,Giovanni Scambia,Amelia Zelnak,Todd M Bauer,Ning Jin,Susanna V Ulahannan,Marco Colleoni,Philippe Aftimos,Mark T A Donoghue,Ezra Rosen,Vasilisa A Rudneva,Melinda L Telli,Susan M Domchek,Matthew D Galsky,Margaret Hoyle,Colombe Chappey,Ross Stewart, John A Blake-Haskins,Timothy A YapJAMA oncology（2023）引用 13|浏览49暂无评分摘要ClinicalTrials.gov Identifier: NCT03565991.更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
